We are live on ! Find out more
SBFMW

Sunshine Biopharma Inc Warrant
SBFMW

2 hedge funds and large institutions have $5.16K invested in Sunshine Biopharma Inc Warrant in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $5.14K → $5.16K (+$24)

0.13% more ownership

Funds ownership: 0.07% → 0.2% (+0.13%)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.37K
2
CS
Clear Street
New York
-$131
3
UBS Group
UBS Group
Switzerland
-$85
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$4.96K -$2.37K -23,239 -34%
UBS Group
2
UBS Group
Switzerland
$198 -$85 -834 -31%
CS
3
Clear Street
New York
– -$131 -1,876 Closed

SBFMW Hedge Fund Activity: Q3 2024 in Review

2 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q3 2024, worth a combined $5.16K — up 0.47% from $5.14K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SBFMW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, cutting an estimated $2.37K.

  • 2 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q3 2024, down from 3 in Q2 2024.
  • Funds reported $5.16K of Sunshine Biopharma Inc Warrant stock for Q3 2024, up 0.47% quarter-over-quarter.
  • 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q3 2024 and 1 closed out, a net change of -1 holder.
  • The largest Sunshine Biopharma Inc Warrant seller in Q3 2024 was Citadel Advisors, an estimated $2.37K sold.

Based on aggregated 13F filings for Q3 2024.